Hormel Foods Corporation — FY2014 Form 10-K
Reporting period: Fiscal year ended October 26, 2014. This is an annual filing, not a standalone fourth-quarter report. The supplied filing text incorporates the financial statements and management’s discussion by reference but does not include their detailed figures.
Business context
Hormel produces and markets branded meat and other food products in the U.S. and internationally. Its five segments are Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, Specialty Foods, and International & Other. The company emphasized branded, value-added products over commodity fresh meat. Wal-Mart accounted for approximately 14.1% of FY2014 revenues, versus 13.9% in FY2013.
Financial and operating metrics
- Revenue, profit, cash flow, margins, debt, and liquidity: The supplied text does not provide clear consolidated FY2014 amounts or comparable-period results. These are contained in incorporated materials not included in the provided text.
- Product revenue mix: Perishable 54.5% (53.3% in FY2013); shelf-stable 19.0% (19.0%); poultry 18.4% (18.8%); other 8.1% (8.9%).
- Acquisitions: Acquired CytoSport on August 11, 2014, for a preliminary $424.3 million in cash, funded with cash on hand and the revolving credit line; up to an additional $20 million may be payable based on performance over two years. Acquired the China SKIPPY business in November 2013 for a final $41.9 million in cash.
- Research and development: Approximately $29.9 million in FY2014, essentially unchanged from FY2013’s $29.9 million and FY2012’s $29.8 million.
- Shareholder returns: Quarterly dividends were $0.20 per share in FY2014, up from $0.17 in FY2013. In the fourth quarter, 665,900 shares were repurchased under the announced program at an average $46.36 per share; 8,187,700 shares remained available for repurchase at period end.
- Capital structure information in supplied text: The exhibit list identifies 4.125% notes due 2021 and a $300 million revolving credit agreement. Outstanding debt balances and revolver availability are not stated clearly.
Changes, outlook, and risks
- Product mix shifted toward perishable items compared with FY2013, while poultry and other each declined as a share of revenues; shelf-stable was unchanged.
- The CytoSport acquisition expanded the portfolio and was partly financed through the revolving line of credit. Its purchase price remained preliminary, and contingent consideration could reach $20 million.
- The filing text provides no clear forward earnings or revenue guidance. Management’s detailed outlook is incorporated by reference but not included here.
- Key operating exposures include fluctuations in pork, turkey, feed-grain, and fuel costs; the company hedges some anticipated grain purchases. It purchased 94% of its hogs under supply contracts and raised turkeys representing approximately 78% of Jennie-O’s required volume.
- Competition is intense. Customer concentration is notable: Wal-Mart represented 14.1% of revenues, and the top five customers accounted for 26%–45% of sales in each segment. The filing says losing one or more leading segment customers could materially harm that segment.
- Various ordinary-course legal proceedings are disclosed; management did not expect known matters, individually or collectively, to materially affect financial condition, results, or liquidity. Management concluded disclosure controls were effective, and reported no material fourth-quarter change in internal control over financial reporting.
Important facts for investors to verify
- Consolidated FY2014 and comparative revenue, earnings, margins, operating cash flow, balance-sheet liquidity, debt, and segment results in the incorporated annual stockholders’ report.
- Final accounting and purchase-price adjustments for CytoSport, its subsequent performance, and any contingent payment.
- Available borrowing capacity and the effect of acquisition financing on debt and liquidity.
- Exposure to input-cost volatility, customer concentration, and the company’s FY2015 outlook and risk-factor disclosures, which are incorporated by reference but absent from the supplied text.